Randomized, phase III trial of figitumumab in combination with erlotinib versus erlotinib alone in patients with nonadenocarcinoma nonsmall-cell lung cancer
Titel:
Randomized, phase III trial of figitumumab in combination with erlotinib versus erlotinib alone in patients with nonadenocarcinoma nonsmall-cell lung cancer
Auteur:
Scagliotti, G.V. Bondarenko, I. Blackhall, F. Barlesi, F. Hsia, T.-C. Jassem, J. Milanowski, J. Popat, S. Sanchez-Torres, J.M. Novello, S. Benner, R.J. Green, S. Molpus, K. Soria, J.-C. Shepherd, F.A.